Axsome Thera (AXSM)
112.74 +2.82 (+2.57%) 13:44 ET [NASDAQ]
111.93 x 100 112.53 x 17
Realtime by (Cboe BZX)
111.93 x 100 112.53 x 17
Realtime 109.93 +0.02 (+0.01%) 09:30 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | AXSM | NUVL | KRYS | ||
| Company | Axsome Thera | Nuvalent Inc Cl A | Krystal Biotech Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 109.94 | 75.70 | 170.83 | ||
| High | 112.13 | 76.83 | 171.60 | ||
| Low | 109.59 | 75.03 | 167.34 | ||
| Last | 112.74 | 75.70 | 171.62 | ||
| Change | +2.82 | -0.17 | +1.05 | ||
| % Change | +2.57% | -0.22% | +0.62% | ||
| Volume | 303,342 | 175,615 | 69,357 | ||
| 20-Day Average Volume | 828,573 | 616,979 | 315,116 | ||
| Previous Close | 109.92 | 75.87 | 170.57 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 103.78 | 69.64 | 168.23 | ||
| 20-Day Raw Stochastic | 97.86% | 96.50% | 63.30% | ||
| 20-Day Relative Strength | 52.02% | 55.62% | 49.13% | ||
| Weighted Alpha | +38.85 | -1.16 | -0.97 | ||
| Today's Opinion | 40% Buy | 56% Sell | 40% Sell | ||
| Previous Opinion | 40% Buy | 56% Sell | 40% Sell | ||
| Last Month's Opinion | 56% Buy | 100% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.94% since 04/23/25 | +5.01% since 04/23/25 | +2.77% since 04/23/25 | ||
| Low | 103.15 on 04/24/25 | 71.60 on 04/24/25 | 163.77 on 04/29/25 | ||
| High | 112.00 on 04/30/25 | 77.11 on 04/29/25 | 172.71 on 04/25/25 | ||
| 1-Month | |||||
| %Chg | -5.96% since 03/28/25 | +4.52% since 03/28/25 | -7.36% since 03/28/25 | ||
| Low | 86.99 on 04/09/25 | 55.53 on 04/09/25 | 150.10 on 04/09/25 | ||
| High | 117.78 on 03/31/25 | 77.11 on 04/29/25 | 182.15 on 04/02/25 | ||
| 3-Month | |||||
| %Chg | +2.40% since 01/30/25 | -12.99% since 01/30/25 | +9.18% since 01/30/25 | ||
| Low | 86.99 on 04/09/25 | 55.53 on 04/09/25 | 146.00 on 02/12/25 | ||
| High | 139.13 on 02/21/25 | 91.50 on 02/06/25 | 197.94 on 03/25/25 | ||
| 6-Month | |||||
| %Chg | +24.60% since 10/30/24 | -15.39% since 10/30/24 | -2.93% since 10/30/24 | ||
| Low | 75.56 on 12/30/24 | 55.53 on 04/09/25 | 141.72 on 01/14/25 | ||
| High | 139.13 on 02/21/25 | 97.65 on 11/25/24 | 207.84 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,409,907 | 5,432,140 | 4,929,132 | ||
| Shares Outstanding, K | 49,219 | 71,598 | 28,898 | ||
| Annual Sales | 385,690,000 | 0 | 290,520,000 | ||
| Annual Net Income | -287,220,000 | -260,760,000 | 89,160,000 | ||
| Last Quarter Sales | 118,770,000 | 0 | 91,140,000 | ||
| Last Quarter Net Income | -74,910,000 | -74,760,000 | 45,480,000 | ||
| 60-Month Beta | 0.88 | 1.43 | 0.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.96 on 02/18/25 | -1.05 on 02/27/25 | 1.52 on 02/19/25 | ||
| Latest Earnings Date | 05/05/25 | 05/08/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 51.12 | ||